Search by Drug Name or NDC
NDC 64980-0561-02 Linezolid 600 mg/1 Details
Linezolid 600 mg/1
Linezolid is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is LINEZOLID.
MedlinePlus Drug Summary
Linezolid is used to treat infections, including pneumonia, and infections of the skin . Linezolid is in a class of antibacterials called oxazolidinones. It works by stopping the growth of bacteria. Antibiotics such as linezolid will not work for colds, flu, and other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 64980-0561-02Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Linezolid
Product Information
NDC | 64980-0561 |
---|---|
Product ID | 64980-561_bf4fa35d-93c9-41c3-a2ae-0298014b8a9f |
Associated GPIs | |
GCN Sequence Number | 045131 |
GCN Sequence Number Description | linezolid TABLET 600 MG ORAL |
HIC3 | W1O |
HIC3 Description | OXAZOLIDINONE ANTIBIOTICS |
GCN | 26870 |
HICL Sequence Number | 021157 |
HICL Sequence Number Description | LINEZOLID |
Brand/Generic | Generic |
Proprietary Name | Linezolid |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Linezolid |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 600 |
Active Ingredient Units | mg/1 |
Substance Name | LINEZOLID |
Labeler Name | Rising Pharma Holdings, Inc. |
Pharmaceutical Class | Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078845 |
Listing Certified Through | 2024-12-31 |
Package
NDC 64980-0561-02 (64980056102)
NDC Package Code | 64980-561-02 |
---|---|
Billing NDC | 64980056102 |
Package | 20 TABLET in 1 BOTTLE (64980-561-02) |
Marketing Start Date | 2023-11-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |